Stanford seems to have found a niche in tiny wireless implants. In the latest development, the university announced that it is developing methods of beaming ultrasound to power implanted "smart chips" for the treatment of conditions like Parkinson's disease.
Engineers have developed a tiny sensor used to measure the brain pressure in lab mice that they believe has the potential to create the electronic equivalent of touch for advanced prosthetics as well as other applications in medicine.
The National Institutes of Health has kicked off its Big Data to Knowledge (BD2K) initiative with an initial $32 million in funding. Harvard, Stanford and other universities received some of the cash to set up Centers of Excellence for Big Data Computing, each of which will tackle a different aspect of turning numbers into biomedical understanding.
Academics hope to enhance a new mouse model created to better understand how pain is transmitted in the body. Ada Poon, an assistant professor of electrical engineering at Stanford University, is working as part of a team to build a wireless device that incorporates existing optogenetics research.
Researchers are developing an implantable sensor for glaucoma that allows intraocular pressure to be read by a smartphone camera. Diagnosis and monitoring now relies on a trip to the ophthalmologist and a reading of intraocular pressure that can vary widely. The implant/smartphone combination is expected to allow at-home monitoring and a series of readings that could improve diagnosis and monitoring of glaucoma patients.
Medical students at Standford are joining the ranks of future surgeons learning how to use Google Glass as an operation tool.
Stanford University is partnering with Plantation, FL-based Neurotrope to study a class of compounds called bryostatins with the aim of developing potential clinical candidates for the treatment of various neurological disorders.
Stanford University electrical engineer Ada Poon has developed a method of powering tiny medical implants such as pacemakers located deep inside the body, potentially paving the way forward for the development of electroceuticals as an alternative, or even replacement, to pharmaceuticals.
The FDA is setting up its first West Coast Center of Excellence in Regulatory Science and Innovation (CERSI) to further strengthen ties with academia and improve its use of informatics and data-driven computer models. The University of California, San Francisco, is housing the CERSI, which it will run in collaboration with scientists at Stanford University.
The FDA has selected Johns Hopkins University, Stanford University and the University of California, San Francisco, for a new initiative aimed at streamlining the drug development and approval process.